Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany Update▼ NegativeAuditor Change9 Aug 2026

Rhi Magnesita India Ltd

The Company and its wholly owned material subsidiary RHI Magnesita India Refractories Limited have received letter today from its statutory auditors.

Rhi Magnesita India Ltd has received letters from its statutory auditors Price Waterhouse Chartered Accountant LLP intending to resign as statutory auditor of the Company and its wholly-owned material subsidiary RHI Magnesita India Refractories Limited on 14 August 2026.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults9 Aug 2026

Medi Assist Healthcare Services Ltd

Press Release-Q1F27- Revenue up 24.1% - Paramount Integration is at its logical closure; AI Platform Contracts Signed ; International Platform Established.

Medi Assist Healthcare Services Ltd reported a 24.1% YoY increase in revenue for Q1 FY27, driven by a 25.5% YoY growth in the India TPA franchise and a 55.5% YoY growth in technology revenue. The company has completed its planned AI platform investment and has begun generating incremental revenue. The international business has transitioned from a seed investment to a structured growth platform, with a first technology deployment contract live in Thailand and a material resource commitment to the growth opportunity.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults9 Aug 2026

Medi Assist Healthcare Services Ltd

Investor Presentation for Q1 FY27

Medi Assist Healthcare Services Ltd has released its Q1 FY27 investor presentation, showcasing a 24.9% YoY growth in total income, with EBITDA and PAT also increasing by 14.3% and 21.9% YoY respectively. The company has achieved a debt-free status with a free cash position of INR 245.5 Cr. The management commentary highlights the company's core engine, the India TPA franchise, and its AI stack, which has moved from investment to early monetization. The company has also completed the paramount integration and is expecting both growth tracks to become meaningful contributors to EBITDA margins over time.

Read more →📎 1 attachment
BSECompany Update▲ PositiveMgmt Change9 Aug 2026

Mahindra & Mahindra Ltd

Please refer the enclosed file

Mahindra & Mahindra Ltd has announced the appointment of Ms. Shveta Arya as Group Chief Strategy Officer, effective September 15, 2026. She will lead the Group Strategy Office and form part of the Senior Management of the Company.

Read more →📎 1 attachment
BSEBoard MeetingResults9 Aug 2026

Novelix Pharmaceuticals Ltd

Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Submission of prior ....

Novelix Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/08/2026 to consider and approve the unaudited standalone financial results for the quarter ended on June 30, 2026.

Read more →📎 1 attachment
BSECompany UpdateResults9 Aug 2026

Shree Refrigerations Ltd

The Company is hereby submitting the Newspaper Advertisement with respect to the 20th AGM of the Company to be held on Monday, 31st August 2026, at 11:30 A.M. (IST) at the Registered Office ....

Shree Refrigerations Ltd has submitted a newspaper advertisement for its 20th Annual General Meeting (AGM) to be held on August 31, 2026, at its registered office in Satara, Maharashtra. The advertisement was published in Financial Express and Sakal newspapers on August 9, 2026.

Read more →📎 1 attachment
BSEBoard MeetingResults9 Aug 2026

Astal Laboratories Ltd

Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Prior intimation of Board ....

Astal Laboratories Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/08/2026 to consider and approve prior intimation of the board meeting, unaudited standalone & consolidated financial results for the quarter ended 30th June, 2026, and limited review report of the auditors.

Read more →📎 1 attachment
BSEBoard MeetingResults9 Aug 2026

Sudarshan Pharma Industries Ltd

Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited Standalone ....

Sudarshan Pharma Industries Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 12/08/2026 to consider and approve Unaudited Standalone Financial Results for the quarter ended 30/06/2026.

Read more →📎 1 attachment
BSEBoard MeetingResults9 Aug 2026

Datacipher Ltd

Datacipher Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Board Meeting Intimation for Board ....

Datacipher Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026, inter alia, to consider and approve the unaudited standalone financial results of the Company for the 1st quarter ended June 30, 2026 of the Financial Year 2026-27.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults9 Aug 2026

Knack Packaging Ltd

Investor Presentation for quarter ended June 30, 2026

Knack Packaging Ltd has announced its un-audited financial results for the first quarter ended June 30, 2026, with revenue from operations at ₹2,624.59 Mn, an increase of 41.10% YoY, and EBITDA margin at 22.35% and PAT margin at 11.53%. The company has a strong capital efficiency with ROCE at 54.73% and ROE at 37.45%. The presentation highlights the company's robust Q1 FY27 performance and its global reach across 74 countries.

Read more →📎 1 attachment
BSEBoard MeetingResults9 Aug 2026

Dolphin Medical Services Ltd

Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Board Meeting Intimation ....

Dolphin Medical Services Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026, inter alia, to consider and approve the unaudited standalone financial results of the Company for the 1st quarter ended June 30, 2026 of the Financial Year 2026-27.

Read more →📎 1 attachment
← PreviousPage 1288 of 2548Next →